152 related articles for article (PubMed ID: 37551941)
21. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
[TBL] [Abstract][Full Text] [Related]
22. Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center.
Yusufov M; Melanson SEF; Kang P; Kematick B; Schiff GD; Chua IS
J Pain Symptom Manage; 2024 Jul; 68(1):e36-e45. PubMed ID: 38599533
[TBL] [Abstract][Full Text] [Related]
23. Utility and application of urine drug testing in chronic pain management with opioids.
Nafziger AN; Bertino JS
Clin J Pain; 2009 Jan; 25(1):73-9. PubMed ID: 19158549
[TBL] [Abstract][Full Text] [Related]
24. Stimulant use and opioid-related harm in patients on long-term opioids for chronic pain.
Appa A; McMahan VM; Long K; Shade SB; Coffin PO
Drug Alcohol Depend; 2024 Mar; 256():111065. PubMed ID: 38245963
[TBL] [Abstract][Full Text] [Related]
25. Compliance with Opioid Therapy: Distinguishing Clinical Characteristics and Demographics Among Patients with Cancer Pain.
Koyyalagunta D; Bruera E; Engle MP; Driver L; Dong W; Demaree C; Novy DM
Pain Med; 2018 Jul; 19(7):1469-1477. PubMed ID: 29016951
[TBL] [Abstract][Full Text] [Related]
26. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
[TBL] [Abstract][Full Text] [Related]
27. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
28. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain.
Starrels JL; Fox AD; Kunins HV; Cunningham CO
J Gen Intern Med; 2012 Nov; 27(11):1521-7. PubMed ID: 22815062
[TBL] [Abstract][Full Text] [Related]
29. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
[TBL] [Abstract][Full Text] [Related]
30. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
Reisfield GM; Goldberger BA; Bertholf RL
J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
[TBL] [Abstract][Full Text] [Related]
31. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
Setnik B; Roland CL; Pixton GC; Sommerville KW
Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
[TBL] [Abstract][Full Text] [Related]
32. Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects.
Lee CT; Vo TT; Cohen AS; Ahmed S; Zhang Y; Mao J; Chen L
Pain Med; 2016 Apr; 17(4):636-43. PubMed ID: 26398237
[TBL] [Abstract][Full Text] [Related]
33. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
[TBL] [Abstract][Full Text] [Related]
34. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
Gupta A; Patton C; Diskina D; Cheatle M
Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
[TBL] [Abstract][Full Text] [Related]
35. Systematic Identification and Categorization of Opioid Prescribing and Dispensing Policies in 16 States and Washington, DC.
Andraka-Christou B; McAvoy E; Ohama M; Smart R; Vaiana ME; Taylor E; Stein BD
Pain Med; 2023 Feb; 24(2):130-138. PubMed ID: 35984301
[TBL] [Abstract][Full Text] [Related]
36. Repeated Quantitative Urine Toxicology Analysis May Improve Chronic Pain Patient Compliance with Opioid Therapy.
Knezevic NN; Khan OM; Beiranvand A; Candido KD
Pain Physician; 2017 Feb; 20(2S):S135-S145. PubMed ID: 28226335
[TBL] [Abstract][Full Text] [Related]
37. What is the role of Urine Drug Testing (UDT) in the management of chronic non-cancer pain with opioids?
Schonwald G
Pain Med; 2012 Jul; 13(7):853-6. PubMed ID: 22804903
[No Abstract] [Full Text] [Related]
38. Development of an Algorithm to Identify Cannabis Urine Drug Test Results within a Multi-Site Electronic Health Record System.
Morasco BJ; Shull SE; Adams MH; Dobscha SK; Lovejoy TI
J Med Syst; 2018 Jul; 42(9):163. PubMed ID: 30043122
[TBL] [Abstract][Full Text] [Related]
39. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
[TBL] [Abstract][Full Text] [Related]
40. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC
J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
